Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.

Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, Huang DW, Xiao W, Powell J, Petrus MN, Yang Y, Phelan JD, Kohlhammer H, Dubois SP, Yoo HM, Bachy E, Webster DE, Yang Y, Xu W, Yu X, Zhao H, Bryant BR, Shimono J, Ishio T, Maeda M, Green PL, Waldmann TA, Staudt LM.

Cancer Cell. 2018 Aug 13;34(2):286-297.e10. doi: 10.1016/j.ccell.2018.06.014. Epub 2018 Jul 26.

PMID:
30057145
2.

Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.

Shimono J, Miyoshi H, Kiyasu J, Kamimura T, Eto T, Miyagishima T, Nagafuji K, Seto M, Teshima T, Ohshima K.

PLoS One. 2018 Apr 11;13(4):e0194525. doi: 10.1371/journal.pone.0194525. eCollection 2018.

3.

Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma.

Shimono J, Miyoshi H, Kato T, Sugio T, Miyawaki K, Kamimura T, Miyagishima T, Eto T, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Oncotarget. 2017 Dec 11;9(2):1717-1725. doi: 10.18632/oncotarget.23138. eCollection 2018 Jan 5.

4.

Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia/lymphoma.

Asano N, Miyoshi H, Kato T, Shimono J, Yoshida N, Kurita D, Sasaki Y, Kawamoto K, Ohshima K, Seto M.

Histopathology. 2018 May;72(6):945-954. doi: 10.1111/his.13461. Epub 2018 Feb 21.

PMID:
29297942
5.

Unilateral conjunctival infiltration of Adult T-cell leukemia/lymphoma. Case report and literature review.

Shimono J, Kaino S, Okada K, Oshimi K, Ishida Y, Takahashi T, Miyagishima T, Teshima T.

J Clin Exp Hematop. 2017;57(3):143-146. doi: 10.3960/jslrt.17027. Review.

6.

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.

7.

Prognostic factors for histiocytic and dendritic cell neoplasms.

Shimono J, Miyoshi H, Arakawa F, Sato K, Furuta T, Muto R, Yanagida E, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Ohshima K.

Oncotarget. 2017 Oct 19;8(58):98723-98732. doi: 10.18632/oncotarget.21920. eCollection 2017 Nov 17.

8.

Whole-Body Vibration Exercise on Hematology and Serum Biochemistry in Healthy Dogs.

Santos IFC, Rahal SC, Shimono J, Tsunemi M, Takahira R, Teixeira CR.

Top Companion Anim Med. 2017 Jun;32(2):86-90. doi: 10.1053/j.tcam.2017.07.006. Epub 2017 Jul 29.

PMID:
28992911
9.

Clinicopathological features of primary splenic follicular lymphoma.

Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Seto M, Teshima T, Ohshima K.

Ann Hematol. 2017 Dec;96(12):2063-2070. doi: 10.1007/s00277-017-3139-y. Epub 2017 Oct 3.

PMID:
28975390
10.

Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.

Shimono J, Miyoshi H, Kiyasu J, Sato K, Kamimura T, Eto T, Miyagishima T, Nagafuji K, Teshima T, Ohshima K.

Br J Haematol. 2017 Sep;178(5):719-727. doi: 10.1111/bjh.14736. Epub 2017 May 11.

PMID:
28493517
11.

Clinical features of diffuse large B-cell lymphoma with polyploidy.

Shimono J, Miyoshi H, Seto M, Teshima T, Ohshima K.

Pathol Int. 2017 Jan;67(1):17-23. doi: 10.1111/pin.12478. Epub 2016 Nov 21.

PMID:
27868293
12.

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K.

Blood. 2016 Sep 8;128(10):1374-81. doi: 10.1182/blood-2016-02-698936. Epub 2016 Jul 14.

13.

Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma.

Yokoyama S, Miyoshi H, Nakashima K, Shimono J, Hashiguchi T, Mitsuoka M, Takamori S, Akagi Y, Ohshima K.

Clin Cancer Res. 2016 Sep 15;22(18):4727-34. doi: 10.1158/1078-0432.CCR-16-0434. Epub 2016 May 10.

14.

CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.

Yoshida N, Miyoshi H, Kato T, Sakata-Yanagimoto M, Niino D, Taniguchi H, Moriuchi Y, Miyahara M, Kurita D, Sasaki Y, Shimono J, Kawamoto K, Utsunomiya A, Imaizumi Y, Seto M, Ohshima K.

J Pathol. 2016 Apr;238(5):621-6. doi: 10.1002/path.4699.

PMID:
26847489
15.

Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma.

Yutaka T, Ito S, Ohigashi H, Naohiro M, Shimono J, Souichi S, Teshima T.

Leuk Lymphoma. 2015;56(11):3216-8. doi: 10.3109/10428194.2015.1026818. Epub 2015 May 12. No abstract available.

PMID:
25760636
16.

[Acute renal tubular damage caused by disseminated Trichosporon infection in primary myelofibrosis].

Shimono J, Tsutsumi Y, Ohigashi H.

Rinsho Ketsueki. 2015 Jan;56(1):21-4. doi: 10.11406/rinketsu.56.21. Japanese.

PMID:
25745963
17.

Analysis of the influence of dabigatran on coagulation factors and inhibitors.

Tsutsumi Y, Shimono J, Ohhigashi H, Ito S, Shiratori S, Teshima T.

Int J Lab Hematol. 2015 Apr;37(2):225-30. doi: 10.1111/ijlh.12270. Epub 2014 Jun 25.

PMID:
24963788
18.

Hepatitis B virus reactivation with rituximab-containing regimen.

Tsutsumi Y, Yamamoto Y, Shimono J, Ohhigashi H, Teshima T.

World J Hepatol. 2013 Nov 27;5(11):612-20. doi: 10.4254/wjh.v5.i11.612. Review.

19.

No effect of humanized CCR monoclonal antibody (mogamulizumab) on treatment-resistant adult T cell leukemia with meningeal infiltration.

Tsutsumi Y, Shimono J, Miyashita N, Teshima T.

Leuk Lymphoma. 2014 Feb;55(2):457-9. doi: 10.3109/10428194.2013.807511. Epub 2013 Jun 24. No abstract available.

PMID:
23697876
20.

Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.

Kainuma M, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Shimono J, Shimoda S, Hayashi J; Kyushu University Liver Disease Study Group.

World J Gastroenterol. 2010 Sep 21;16(35):4400-9.

21.

Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study.

Mizuki A, Tatemichi M, Tsukada N, Nagamatsu R, Kawaguchi M, Itoshima T, Maruyama S, Satou A, Imari Y, Kawatoko T, Shimono J, Nagata H; SAISEIKAI ASSOCIATION FOR THE STUDY OF LIVER DISEASES (SASLD).

Oncol Lett. 2010 Sep;1(5):855-859. Epub 2010 Sep 1.

22.

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group.

Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Masumoto A, Maruyama T, Nakamuta M, Enjoji M, Azuma K, Shimono J, Sakai H, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1094-104. doi: 10.1111/j.1440-1746.2008.05319.x. Epub 2008 Feb 3.

PMID:
18248381
24.

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

Nakamuta M, Kotoh K, Enjoji M, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Tanabe Y, Hayashi J.

Comp Hepatol. 2007 May 1;6:3.

25.

Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.

Furusyo N, Katoh M, Tanabe Y, Kajiwara E, Maruyama T, Shimono J, Sakai H, Nakamuta M, Nomura H, Masumoto A, Shimoda S, Takahashi K, Azuma K, Hayashi J; Kyushu University Liver Disease Study Group.

World J Gastroenterol. 2006 Feb 7;12(5):784-90.

26.

Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.

Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J.

World J Gastroenterol. 2006 Jan 28;12(4):561-7.

27.

Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

Nakamuta M, Morizono S, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Kotoh K, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group.

World J Gastroenterol. 2005 Nov 28;11(44):6948-53.

28.

Efficacy of prolonged treatment following combination with ribavirin and interferon for chronic hepatitis type C: A pilot study.

Nomura H, Kashiwagi Y, Nakashima H, Tanimoto H, Shimono J, Kajiwara E, Maruyama T, Yamashita N, Nagano M, Higashi M, Mukai T, Matsui Y, Hayashi J, Kashiwagi S, Ishibashi H.

Hepatol Res. 2005 Apr;31(4):211-6.

PMID:
15866521
29.

Body surface area is an independent factor contributing to the effects of lamivudine treatment.

Nakamuta M, Kotoh K, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Enjoji M, Hayashi J; Kyushu University Liver Disease Study Group.

Hepatol Res. 2005 Jan;31(1):13-17. Epub 2004 Dec 28.

PMID:
15652465
30.

Factors contributing to ribavirin-induced anemia.

Nomura H, Tanimoto H, Kajiwara E, Shimono J, Maruyama T, Yamashita N, Nagano M, Higashi M, Mukai T, Matsui Y, Hayashi J, Kashiwagi S, Ishibashi H.

J Gastroenterol Hepatol. 2004 Nov;19(11):1312-7.

PMID:
15482540
31.

Primary biliary cirrhosis associated with ulcerative colitis.

Nakayama M, Tsuji H, Shimono J, Azuma K, Ogata H, Matsumoto T, Aoyagi K, Fujishima M, Iida M.

Fukuoka Igaku Zasshi. 2001 Oct;92(10):354-9.

PMID:
11729641
32.

Autoimmune cholangiopathy associated with rheumatoid arthritis.

Ogata H, Tsuji H, Hashiguchi M, Azuma K, Shimono J, Fujishima M.

Hepatogastroenterology. 2000 Nov-Dec;47(36):1533-4.

PMID:
11148995
33.

Hepatocellular carcinoma with metastasis to the rib complicated by hemothorax. An autopsy case.

Ogata H, Tsuji H, Hashiguchi M, Azuma K, Shimono J, Fujishima M.

Fukuoka Igaku Zasshi. 1999 Aug;90(8):342-6.

PMID:
10496047
34.

Ruptured duodenal varices: an autopsy case report.

Hashiguchi M, Tsuji H, Shimono J, Azuma K, Fujishima M.

Hepatogastroenterology. 1999 May-Jun;46(27):1751-4.

PMID:
10430337
35.

Recurring encephalopathy abolished by gastrorenal shunt ligation in a diabetic hemodialysis patient.

Shimono J, Tsuji H, Azuma K, Hashiguchi M, Fujishima M.

Am J Gastroenterol. 1998 Feb;93(2):270-2.

PMID:
9468259
36.

A rare case of hepatic injury associated with ovarian hyperstimulation syndrome.

Shimono J, Tsuji H, Azuma K, Hashiguchi M, Fujishima M.

Am J Gastroenterol. 1998 Jan;93(1):123-4.

PMID:
9448194
37.

[Thyroid function in patients with Yusho: 28 year follow-up study].

Tsuji H, Sato K, Shimono J, Azuma K, Hashiguchi M, Fujishima M.

Fukuoka Igaku Zasshi. 1997 May;88(5):231-5. Japanese.

PMID:
9194348

Supplemental Content

Loading ...
Support Center